Literature DB >> 12021364

Early pathogenesis of transmucosal feline immunodeficiency virus infection.

Leslie A Obert1, Edward A Hoover.   

Abstract

To identify the early target cells and tissues in transmucosal feline immunodeficiency virus (FIV) infection, cats were exposed to a clade C FIV isolate via the oral-nasal or vaginal mucosa and multiple tissues were examined by virus isolation coculture (VI), DNA PCR, catalyzed tyramide signal-amplified in situ hybridization (TSA-ISH), and immunohistochemistry between days 1 and 12 postinoculation (p.i.). FIV RNA was detected in tonsil and oral or vaginal mucosa as early as 1 day p.i. by TSA-ISH and in retropharyngeal, tracheobronchial, or external iliac lymph nodes and sometimes in spleen or blood mononuclear cells by day 2, indicating that regional and distant spread of virus-infected cells occurred rapidly after mucosal exposure. By day 8, viral RNA, DNA, and culturable virus were uniformly detected in regional and distant tissues, connoting systemic infection. TSA-ISH proved more sensitive than DNA PCR in detecting early FIV-infected cells. In mucosal tissues, the earliest demonstrable FIV-bearing cells were either within or subjacent to the mucosal epithelium or were in germinal centers of regional lymph nodes. The FIV(+) cells were of either of two morphological types, large stellate or small round. Those FIV RNA(+) cells which could be colabeled for a phenotype marker, were labeled for either dendritic-cell-associated protein p55 or T-lymphocyte receptor antigen CD3. These studies indicate that FIV crosses mucous membranes within hours after exposure and rapidly traffics via dendritic and T cells to systemic lymphoid tissues, a pathway similar to that thought to occur in the initial phase of infection by the human and simian immunodeficiency viruses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021364      PMCID: PMC136212          DOI: 10.1128/jvi.76.12.6311-6322.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  89 in total

Review 1.  Oral transmission of HIV.

Authors:  R B Rothenberg; M Scarlett; C del Rio; D Reznik; C O'Daniels
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

2.  Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice.

Authors:  C Masurier; B Salomon; N Guettari; C Pioche; F Lachapelle; M Guigon; D Klatzmann
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 (HIV-1) infection and transcytosis activity of a HIV-1 susceptible clone from HeLa cell.

Authors:  K Morizono; S Harada
Journal:  Microbiol Immunol       Date:  1998       Impact factor: 1.955

4.  Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection.

Authors:  C Nielsen; C Pedersen; J D Lundgren; J Gerstoft
Journal:  AIDS       Date:  1993-08       Impact factor: 4.177

5.  The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum.

Authors:  T R Moench; K J Whaley; T D Mandrell; B D Bishop; C J Witt; R A Cone
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

6.  Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection.

Authors:  R K Sellon; H L Jordan; S Kennedy-Stoskopf; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells.

Authors:  E M Poeschla; D J Looney
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns.

Authors:  D L Sodora; E G Shpaer; B E Kitchell; S W Dow; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques.

Authors:  C J Miller; P Vogel; N J Alexander; S Dandekar; A G Hendrickx; P A Marx
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

10.  Summary of the National Institutes of Health workshop on primary human immunodeficiency virus type 1 infection.

Authors:  M T Niu; J A Jermano; P Reichelderfer; S M Schnittman
Journal:  AIDS Res Hum Retroviruses       Date:  1993-09       Impact factor: 2.205

View more
  17 in total

1.  Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses.

Authors:  Mariko Kohmoto; Yasuhiro Ikeda; Eiji Sato; Yorihiro Nishimura; Yasuo Inoshima; Masayuki Shimojima; Yukinobu Tohya; Takeshi Mikami; Takayuki Miyazawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

2.  Concomitant feline immunodeficiency virus (FIV) and Mycoplasma haemofelis in a barn cat.

Authors:  Alejandra Ceballos-Vasquez
Journal:  Can Vet J       Date:  2018-03       Impact factor: 1.008

3.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.

Authors:  Mauro Pistello; Donatella Matteucci; Francesca Bonci; Patrizia Isola; Paola Mazzetti; Lucia Zaccaro; Antonio Merico; Daniela Del Mauro; Norman Flynn; Mauro Bendinelli
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.

Authors:  Malou C Gemeniano; Earl T Sawai; Christian M Leutenegger; Ellen E Sparger
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  Molecular characterization of feline immunodeficiency virus budding.

Authors:  Benjamin G Luttge; Miranda Shehu-Xhilaga; Dimiter G Demirov; Catherine S Adamson; Ferri Soheilian; Kunio Nagashima; Andrew G Stephen; Robert J Fisher; Eric O Freed
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 6.  Utilizing the FIV model to understand dendritic cell dysfunction and the potential role of dendritic cell immunization in HIV infection.

Authors:  Tracy L Lehman; Kevin P O'Halloran; Edward A Hoover; Paul R Avery
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

7.  Immunohistochemical localization of feline immunodeficiency virus using native species antibodies.

Authors:  Arlin B Rogers; Candace K Mathiason; Edward A Hoover
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

8.  Altered bone marrow dendritic cell cytokine production to toll-like receptor and CD40 ligation during chronic feline immunodeficiency virus infection.

Authors:  Tracy L Lehman; Kevin P O'Halloran; Samantha A Fallon; Lindsey M Habermann; Jennifer A Campbell; Shila Nordone; Gregg A Dean; Edward A Hoover; Paul R Avery
Journal:  Immunology       Date:  2008-09-02       Impact factor: 7.397

Review 9.  Feline immunodeficiency virus neuropathogenesis: from cats to calcium.

Authors:  Rick B Meeker
Journal:  J Neuroimmune Pharmacol       Date:  2006-11-28       Impact factor: 4.147

10.  Mucosal challenge with cell-associated or cell-free feline immunodeficiency virus induces rapid and distinctly different patterns of phenotypic change in the mucosal and systemic immune systems.

Authors:  Kristina E Howard; Mary Jo Burkhard
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.